Cargando…
Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with persistent systemic inflammation. Anti-inflammatory therapies have been shown to decrease acute exacerbations of COPD. The antidiabetic medication metformin decreases oxidative stress and inflammation and may benefit patient...
Autores principales: | Bishwakarma, Raju, Zhang, Wei, Lin, Yu-Li, Kuo, Yong-Fang, Cardenas, Victor J, Sharma, Gulshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842767/ https://www.ncbi.nlm.nih.gov/pubmed/29551895 http://dx.doi.org/10.2147/COPD.S150047 |
Ejemplares similares
-
Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
por: Bishwakarma, Raju, et al.
Publicado: (2017) -
Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease Discharged from Coronavirus 2019 Hospitalization
por: Puebla Neira, Daniel, et al.
Publicado: (2023) -
Oxygen Therapy Use in Older Adults with Chronic Obstructive Pulmonary Disease
por: Nishi, Shawn P. E., et al.
Publicado: (2015) -
Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease
por: Ho, Te-Wei, et al.
Publicado: (2019) -
The Coexistence of Chronic Obstructive Pulmonary Disease and Heart Failure
por: Khalid, Khizer, et al.
Publicado: (2021)